St. Joseph's Health Centre
Toronto M6R 1B5
1 studies enrolling now · 2 studies all time
What they study most
Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-small Cell Lung Cancer
Studies at this site
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
- A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed